Reports suggest in the mouse vaccine model, MCL triggered the regression of tumors by inducing ICD, involving the DCs maturation, stimulation of CD4 and CD8 T cells, and release of HMGB (28). This evidence concerns the gene CD8A and mantle cell lymphoma.